Deep Track Capital, LP - May 6, 2025 SCHEDULE 13G Report for Oruka Therapeutics, Inc. Common Stock, par value $0.001 per share (ORKA)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Oruka Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
ORKA
Shares outstanding
37.4M shares
Disclosed Ownership
1.9M shares
Ownership
5.07%
Form type
SCHEDULE 13G
Date filed
5/13/2025, 04:32 PM
Date of event
May 6, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 5.07% 1.9M 0 1.9M /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 5.07% 1.9M 0 1.9M /s/ David Kroin David Kroin, Director
David Kroin 5.07% 1.9M 0 1.9M /s/ David Kroin David Kroin